Go offline with the Player FM app!
Innovation is a series of small steps :: Dr. Michael D Abramoff
Manage episode 373831631 series 2936072
Michael D. Abramoff, MD, Ph.D., a visionary retina specialist, computer scientist, and entrepreneur. Dr. Abramoff shares his view of innovation as a series of small steps and how he works to ensure progress at every stage.
More about our guest:
Michael D. Abramoff, MD, PhD, is a fellowship-trained retina specialist, computer scientist and entrepreneur. He is Founder and Executive Chairman of Digital Diagnostics, the first company ever to receive FDA clearance for an autonomous AI diagnostic system. To transform the quality, accessibility, and affordability of global healthcare through the automation of medical diagnosis and treatment. Dr. Abramoff (gold Fellow ARVO, Fellow IEEE) is the Robert C. Watzke, MD Professor of Ophthalmology and Visual Sciences at the University of Iowa, with a joint appointment in the College of Engineering.
Dr. Abramoff is the Founder and Executive Chairman of Digital Diagnostics, the Autonomous AI diagnostics company that was the first in any field of medicine to get FDA clearance for an autonomous AI. In primary care, the AI system can instantaneously diagnose diabetic retinopathy (including macular edema) at the point-of-care. Dr. Abramoff developed an ethical foundation for autonomous AI that was used during the design and validation, and regulatory and payment pathways for autonomous AI. As the author of over 350 peer-reviewed publications in this field, he has been cited over 42,000 times, and is the inventor on 20 issued patents and many patent applications. Dr. Abramoff has mentored dozens of engineering graduate students, ophthalmology residents, and retina fellows. His passion is to use AI to improve the affordability, accessibility and quality of care.
Know more about her and their company here:
- Dr. Michael D. Abramoff
- Digital Diagnostics
- Article highlight: 1 in 4 People With Diabetes Have This Sight-Threatening Condition, Study Finds
------------------------------------------------------------
Episode Guide:
0:00 - Intro
1:30 - What is Innovation?
2:40 - Breaking down the "steps"
6:11 - Ensuring progress in every step
10:15 - Diabetes Care in the US
12:57 - Diabetic Retinopathy
14:25 - Benefits of getting more people screened
15:57 - Bringing together different domains
17:22 - What is a bio-ethicist?
20:38 - What isn't innovation?
28:59 - What's next for the company?
--------------------------
OUTLAST Consulting offers professional development and strategic advisory services in the areas of innovation and diversity management.
128 episodes
Manage episode 373831631 series 2936072
Michael D. Abramoff, MD, Ph.D., a visionary retina specialist, computer scientist, and entrepreneur. Dr. Abramoff shares his view of innovation as a series of small steps and how he works to ensure progress at every stage.
More about our guest:
Michael D. Abramoff, MD, PhD, is a fellowship-trained retina specialist, computer scientist and entrepreneur. He is Founder and Executive Chairman of Digital Diagnostics, the first company ever to receive FDA clearance for an autonomous AI diagnostic system. To transform the quality, accessibility, and affordability of global healthcare through the automation of medical diagnosis and treatment. Dr. Abramoff (gold Fellow ARVO, Fellow IEEE) is the Robert C. Watzke, MD Professor of Ophthalmology and Visual Sciences at the University of Iowa, with a joint appointment in the College of Engineering.
Dr. Abramoff is the Founder and Executive Chairman of Digital Diagnostics, the Autonomous AI diagnostics company that was the first in any field of medicine to get FDA clearance for an autonomous AI. In primary care, the AI system can instantaneously diagnose diabetic retinopathy (including macular edema) at the point-of-care. Dr. Abramoff developed an ethical foundation for autonomous AI that was used during the design and validation, and regulatory and payment pathways for autonomous AI. As the author of over 350 peer-reviewed publications in this field, he has been cited over 42,000 times, and is the inventor on 20 issued patents and many patent applications. Dr. Abramoff has mentored dozens of engineering graduate students, ophthalmology residents, and retina fellows. His passion is to use AI to improve the affordability, accessibility and quality of care.
Know more about her and their company here:
- Dr. Michael D. Abramoff
- Digital Diagnostics
- Article highlight: 1 in 4 People With Diabetes Have This Sight-Threatening Condition, Study Finds
------------------------------------------------------------
Episode Guide:
0:00 - Intro
1:30 - What is Innovation?
2:40 - Breaking down the "steps"
6:11 - Ensuring progress in every step
10:15 - Diabetes Care in the US
12:57 - Diabetic Retinopathy
14:25 - Benefits of getting more people screened
15:57 - Bringing together different domains
17:22 - What is a bio-ethicist?
20:38 - What isn't innovation?
28:59 - What's next for the company?
--------------------------
OUTLAST Consulting offers professional development and strategic advisory services in the areas of innovation and diversity management.
128 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.